
  
    
      
        Background_NNP
        The_DT discovery_NN that_IN the_DT jellyfish_NN green_JJ fluorescent_NN
        protein_NN (_( GFP_NNP )_) can_MD form_VB a_DT functional_JJ fluorophore_NN without_IN
        other_JJ gene_NN products_NNS or_CC co-factors_JJ [_NN 1_CD ]_NN was_VBD rapidly_RB
        followed_VBN by_IN reports_NNS that_IN GFP_NNP can_MD be_VB used_VBN to_TO create_VB
        fluorescent_NN fusion_NN proteins_NNS [_NN e_SYM ._. g_SYM ._. [_NN 2_CD 3_CD ]_NN ]_NN ._. For_IN the_DT first_JJ
        time_NN ,_, it_PRP became_VBD possible_JJ to_TO create_VB a_DT wide_JJ variety_NN of_IN
        genetically_RB encodable_JJ fluorescent_NN fusion_NN proteins_NNS that_WDT
        could_MD be_VB followed_VBN in_IN living_VBG systems_NNS [_NN reviewed_VBN in_IN :_: [_NN 4_CD ]_NN ]_NN ._.
        Most_JJS GFP_NNP fusion_NN proteins_NNS have_VBP been_VBN built_VBN by_IN placing_VBG GFP_NNP at_IN
        either_DT the_DT N-_NNP or_CC C-_NNP terminus_JJ of_IN the_DT host_NN protein_NN ._. This_DT can_MD ,_,
        however_RB ,_, destroy_VBP the_DT function_NN of_IN some_DT host_NN proteins_NNS ._. The_DT
        alternative_NN is_VBZ to_TO insert_VB GFP_NNP into_IN the_DT middle_NN of_IN the_DT host_NN
        protein_NN [_NN 5_CD 6_CD 7_CD 8_CD ]_NN ._. Unfortunately_RB ,_, finding_VBG a_DT permissive_JJ
        location_NN for_IN insertion_NN of_IN the_DT GFP_NNP can_MD be_VB problematic_JJ and_CC
        time_NN consuming_NN ._.
        One_CD way_NN of_IN speeding_VBG the_DT process_NN is_VBZ to_TO randomly_RB generate_VB
        libraries_NNS of_IN GFP_NNP fusion_NN proteins_NNS and_CC then_RB screen_VB for_IN clones_NNS
        that_WDT encode_NN functional_JJ ,_, fluorescent_NN proteins_NNS ._. One_CD group_NN
        used_VBD a_DT combination_NN of_IN nick_NN translation_NN and_CC nuclease_NN S_NNP 1_CD
        treatment_NN to_TO randomly_RB insert_VB GFP_NNP into_IN a_DT cAMP-dependent_JJ
        protein_NN kinase_NN regulatory_JJ subunit_NN from_IN 
        Dictyostelium_NNP [_NN 6_CD ]_NN ._. A_DT surprisingly_RB
        large_JJ number_NN of_IN the_DT resulting_VBG fusion_NN proteins_NNS were_VBD
        fluorescent_NN and_CC retained_VBD cAMP_NN binding_JJ ,_, demonstrating_VBG that_IN
        this_DT can_MD be_VB a_DT powerful_JJ approach_NN ._. A_DT weakness_NN of_IN this_DT
        strategy_NN ,_, however_RB ,_, is_VBZ that_IN it_PRP can_MD produce_VB deletions_NNS in_IN the_DT
        host_NN sequence_NN ._. Another_DT approach_NN is_VBZ to_TO use_VB the_DT random_JJ
        behavior_NN of_IN a_DT transposon_NN to_TO insert_VB GFP_NNP into_IN many_JJ different_JJ
        places_NNS in_IN a_DT target_NN protein_NN ._. Two_CD synthetic_JJ transposons_NNS have_VBP
        been_VBN reported_VBN that_WDT can_MD produce_VB GFP_NNP fusion_NN proteins_NNS [_NN 9_CD 10_CD ]_NN
        ._. The_DT design_NN of_IN these_DT transposons_NNS included_VBD additional_JJ
        protein_NN domains_NNS or_CC linkers_NNS between_IN the_DT GFP_NNP and_CC the_DT target_NN
        protein_NN ,_, however_RB ,_, and_CC little_JJ is_VBZ known_VBN about_IN how_WRB many_JJ of_IN the_DT
        resulting_VBG proteins_NNS continued_VBD to_TO function_VB ._. We_PRP reasoned_VBD that_IN
        a_DT 
        Tn_NNP 5_CD transposon_NN [_NN 11_CD 12_CD ]_NN could_MD be_VB
        designed_VBN that_WDT would_MD generate_VB GFP_NNP fusion_NN proteins_NNS with_IN
        relatively_RB short_JJ linkers_NNS (_( ~_NN 7_CD amino_JJ acids_NNS )_) between_IN the_DT GFP_NNP
        and_CC the_DT host_NN protein_NN analogous_JJ to_TO GFP_NNP fusion_NN proteins_NNS that_WDT
        have_VBP already_RB been_VBN shown_VBN to_TO function_VB [_NN 6_CD 8_CD ]_NN ._. To_TO test_VB this_DT
        approach_NN ,_, we_PRP targeted_VBD the_DT G_NNP protein_NN subunit_NN α_NN 
        s_VBZ and_CC the_DT glutamate_NN receptor_NN subunit_NN
        GluR_NNP 1_CD ._.
      
      
        Results_NNS
        Changes_NNS have_VBP been_VBN made_VBN to_TO the_DT 
        Tn_NNP 5_CD transposon_NN ,_, and_CC its_PRP$ transposase_NN ,_,
        that_IN in_IN concert_NN produce_VBP a_DT hyperactive_JJ transposon_NN capable_JJ of_IN
        a_DT 1_CD %_NN insertion_NN frequency_NN in_IN an_DT 
        in_IN vitro_NN reaction_NN [_NN reviewed_VBN in_IN :_: [_NN 12_CD
        ]_NN ]_NN ._. This_DT hyperactive_JJ 
        Tn_NNP 5_CD transposon_NN is_VBZ defined_VBN as_IN any_DT
        sequence_NN flanked_JJ by_IN the_DT inverted_JJ 19_CD base_NN pair_NN repeats_VBZ known_VBN
        as_IN mosaic_JJ ends_VBZ (_( MEs_NNP )_) ._. The_DT recombinant_JJ 
        Tn_NNP 5_CD transposase_NN binds_NNS these_DT ME_NNP
        sequences_NNS and_CC ,_, in_IN the_DT presence_NN of_IN Mg_NNP 2_CD +_NN ,_, catalyzes_NNS the_DT
        random_JJ insertion_NN of_IN the_DT transposon_NN into_IN target_NN DNA_NNP in_IN a_DT
        complex_JJ process_NN that_WDT involves_VBZ generating_VBG a_DT 9_CD base_NN pair_NN
        staggered_JJ nick_NN in_IN the_DT target_NN ._. This_DT staggered_JJ nick_NN is_VBZ
        subsequently_RB repaired_VBN to_TO produce_VB a_DT 9_CD base_NN pair_NN duplication_NN
        of_IN the_DT target_NN sequence_NN that_IN flanks_NNS the_DT inserted_VBN transposon_NN ._.
        Two_CD possible_JJ reading_NN frames_NNS extend_VBP through_IN the_DT MEs_NNP of_IN the_DT 
        Tn_NNP 5_CD transposon_NN ._. Our_PRP$ initial_JJ GFP_NNP
        transposon_NN ,_, <_NN EGFP-V_NNP >_NN ,_, was_VBD created_VBN by_IN placing_VBG the_DT
        sequence_NN encoding_VBG enhanced_VBN green_JJ fluorescent_NN protein_NN (_( EGFP_NNP )_)
        in_IN one_CD of_IN these_DT frames_NNS such_JJ that_IN if_IN the_DT transposon_NN landed_VBD
        in_IN another_DT coding_VBG sequence_NN ,_, in_IN the_DT correct_JJ orientation_NN and_CC
        frame_NN ,_, it_PRP would_MD produce_VB a_DT GFP_NNP fusion_NN protein_NN (_( figure_NN 1_CD A_DT )_) ._.
        The_DT low_JJ probability_NN of_IN transposition_NN in_IN an_DT 
        in_IN vitro_NN reaction_NN made_VBD it_PRP necessary_JJ
        to_TO include_VB antibiotic_JJ resistance_NN ,_, so_RB 
        Kan_NNP 
        r_LS was_VBD added_VBN to_TO the_DT transposon_NN flanked_JJ
        by_IN 
        Srf_NNP I_PRP restriction_NN sites_NNS that_WDT can_MD be_VB
        used_VBN to_TO subsequently_RB remove_VB it_PRP ._.
        An_DT epitope_NN tagged_VBN version_NN of_IN the_DT G-_NNP protein_NN subunit_NN α_NN 
        s_VBZ (_( α_NN 
        s_VBZ 
        EE_NNP )_) was_VBD chosen_VBN as_IN the_DT first_JJ target_NN
        (_( figure_NN 1_CD B_NNP )_) ._. Previous_JJ studies_NNS have_VBP shown_VBN that_IN the_DT N-_NNP and_CC
        C-_NNP termini_NN of_IN α_NN 
        s_VBZ are_VBP important_JJ for_IN its_PRP$ interactions_NNS
        with_IN receptors_NNS ,_, G-_NNP protein_NN β_NN and_CC γ_NN subunits_NNS ,_, and_CC the_DT plasma_NN
        membrane_NN [_NN 13_CD 14_CD ]_NN ,_, so_RB placing_VBG GFP_NNP within_IN internal_JJ regions_NNS
        of_IN α_NN 
        s_VBZ is_VBZ more_RBR likely_JJ to_TO generate_VB a_DT
        functional_JJ ,_, fluorescent_NN subunit_NN [_NN 8_CD ]_NN ._. Moreover_RB ,_, the_DT
        structure_NN of_IN α_NN 
        s_VBZ has_VBZ been_VBN solved_VBN [_NN 15_CD ]_NN ,_, making_VBG it_PRP
        possible_JJ to_TO interpret_VB the_DT results_NNS in_IN the_DT context_NN of_IN the_DT
        three-dimensional_JJ structure_NN ._. After_IN transposition_NN and_CC
        transformation_NN ,_, colonies_NNS expressing_VBG dual_JJ antibiotic_JJ
        resistance_NN were_VBD screened_VBD with_IN PCR_NNP to_TO identify_VB clones_NNS in_IN
        which_WDT <_NN EGFP-V_NNP >_NN had_VBD landed_VBN in_IN the_DT correct_JJ orientation_NN
        within_IN the_DT coding_VBG region_NN (_( figure_NN 1_CD C_NNP )_) ._. Assuming_VBG that_IN 
        Tn_NNP 5_CD behavior_NN is_VBZ random_JJ ,_, the_DT
        probability_NN that_DT <_NN EGFP-V_NNP >_NN will_MD land_VB in_IN the_DT α_NN 
        s_VBZ 
        EE_NNP coding_VBG sequence_NN during_IN
        transposition_NN should_MD be_VB the_DT ratio_NN of_IN the_DT coding_VBG sequence_NN to_TO
        the_DT size_NN of_IN the_DT total_JJ plasmid_NN (_( 18_CD ._. 5_LS %_NN )_) ._. However_RB ,_,
        transpositions_NNS that_WDT disrupt_VB critical_JJ elements_NNS of_IN the_DT
        plasmid_NN (_( the_DT plasmid_NN origin_NN or_CC the_DT 
        Amp_NNP 
        r_LS gene_NN )_) should_MD not_RB be_VB recovered_VBN after_IN
        transformation_NN ,_, so_IN the_DT predicted_VBN probability_NN of_IN observed_VBD
        transpositions_NNS within_IN the_DT α_NN 
        s_VBZ 
        EE_NNP coding_VBG sequence_NN increases_NNS to_TO
        23_CD ._. 8_CD %_NN ,_, with_IN half_NN of_IN these_DT (_( 11_CD ._. 9_CD %_NN )_) being_VBG in_IN the_DT correct_JJ
        orientation_NN ._. PCR_NNP screening_NN of_IN 384_CD 
        Amp_NNP 
        r_LS +_NN 
        Kan_NNP 
        r_LS resistant_JJ colonies_NNS identified_VBD 44_CD
        clones_NNS with_IN <_NN EGFP-V_NNP >_NN insertions_NNS within_IN the_DT α_NN 
        s_VBZ 
        EE_NNP coding_VBG region_NN in_IN the_DT correct_JJ
        orientation_NN (_( 11_CD ._. 4_LS %_NN )_) ._.
        Each_DT clone_NN containing_VBG an_DT in-frame_JJ insertion_NN should_MD
        encode_NN a_DT truncated_JJ α_NN 
        s_VBZ protein_NN with_IN GFP_NNP at_IN the_DT
        carboxy-terminus_JJ due_NN to_TO a_DT stop_NN codon_NN in_IN the_DT 
        Kan_NNP 
        r_LS ._. Thirty-five_CD of_IN the_DT PCR-positive_NNP
        clones_NNS were_VBD transiently_RB expressed_VBN in_IN HEK_NNP 293_CD cells_NNS ,_, and_CC 13_CD
        were_VBD fluorescent_NN ._. Sequencing_NNP confirmed_VBD that_IN the_DT 13_CD
        fluorescent_NN constructs_NNS were_VBD truncated_JJ α_NN 
        s_VBZ -_: GFP_NNP fusion_NN proteins_NNS (_( with_IN 12_CD being_VBG
        unique_JJ insertions_NNS )_) and_CC that_IN the_DT remaining_VBG 22_CD <_NN EGFP-V_NNP >_NN
        insertions_NNS were_VBD out_IN of_IN frame_NN (_( figure_NN 2_CD A_DT )_) ._. The_DT 12_CD clones_NNS
        encoding_VBG unique_JJ α_NN 
        s_VBZ -_: 
        GFP_NNP fusion_NN proteins_NNS were_VBD digested_VBN
        with_IN 
        Srf_NNP I_PRP and_CC re-ligated_JJ to_TO create_VB
        full-length_JJ fusion_NN proteins_NNS (_( figure_NN 2_CD B_NNP )_) ._. Transient_NNP
        expression_NN of_IN each_DT of_IN the_DT 12_CD α_NN 
        s_VBZ -_: GFP_NNP fusion_NN proteins_NNS in_IN HEK_NNP 293_CD cells_NNS
        produced_VBD a_DT fluorescent_NN signal_NN ._. This_DT is_VBZ surprising_JJ because_IN
        several_JJ insertions_NNS appear_VBP to_TO be_VB in_IN internal_JJ and_CC /_NN or_CC rigid_JJ
        secondary_JJ protein_NN structures_NNS (_( figure_NN 3_LS )_) ._. It_PRP appears_VBZ that_IN
        the_DT folding_NN of_IN GFP_NNP to_TO form_VB a_DT fluorophore_NN is_VBZ
        thermodynamically_RB favorable_JJ at_IN most_JJS insertion_NN sites_NNS ._.
        To_TO determine_VB what_WP effect_NN the_DT GFP_NNP insertions_NNS had_VBD on_IN α_NN 
        s_VBZ localization_NN ,_, the_DT full-length_JJ fusion_NN
        proteins_NNS were_VBD transiently_RB co-expressed_JJ in_IN HEK_NNP 293_CD cells_NNS
        with_IN G_NNP protein_NN subunits_NNS β_NN 
        1_CD and_CC γ_NN 
        7_CD ,_, which_WDT have_VBP been_VBN shown_VBN to_TO mediate_VB
        signaling_VBG between_IN the_DT β-adrenergic_JJ receptor_NN and_CC G_NNP 
        s_VBZ [_NN 16_CD ]_NN ._. Amino-_NNP and_CC carboxy-terminus_JJ
        GFP_NNP fusions_NNS ,_, α_NN 
        s_VBZ -_: GFP_NNP (_( N_NNP )_) and_CC α_NN 
        s_VBZ -_: GFP_NNP (_( C_NNP )_) ,_, respectively_RB ,_, were_VBD also_RB
        co-expressed_JJ with_IN β_NN 
        1_CD and_CC γ_NN 
        7_CD for_IN comparison_NN ._. The_DT end-labeled_JJ GFP_NNP
        fusions_NNS and_CC two_CD of_IN the_DT transposon_NN insertions_NNS ,_, α_NN 
        s_VBZ -_: GFP_NNP (_( 18_CD -_: 20_CD )_) and_CC α_NN 
        s_VBZ -_: GFP_NNP (_( 92_CD -_: 94_CD )_) ,_, showed_VBD clear_JJ localization_NN
        to_TO the_DT plasma_NN membrane_NN (_( figure_NN 4_CD A_DT )_) ._. The_DT remaining_VBG 10_CD fusion_NN
        proteins_NNS displayed_VBD a_DT uniform_NN fluorescence_NN signal_NN throughout_IN
        the_DT cytoplasm_NN (_( figure_NN 4_CD B_NNP )_) ._.
        The_DT fusion_NN proteins_NNS were_VBD tested_VBN for_IN function_NN by_IN assaying_VBG
        their_PRP$ abilities_NNS to_TO stimulate_VB adenylyl_NN cyclase_NN in_IN response_NN
        to_TO receptor_NN stimulation_NN ._. They_PRP were_VBD co-expressed_JJ with_IN the_DT
        luteinizing_VBG hormone_NN (_( LH_NNP )_) receptor_NN in_IN HEK_NNP 293_CD cells_NNS and_CC cAMP_NN
        accumulation_NN was_VBD measured_VBN in_IN both_DT the_DT presence_NN and_CC absence_NN
        of_IN the_DT LH_NNP receptor_NN agonist_NN ,_, human_JJ chorionic_JJ gonadotropin_NN
        (_( hCG_NN )_) ._. Basal_NNP and_CC stimulated_VBN cAMP_NN accumulation_NN in_IN cells_NNS
        expressing_VBG α_NN 
        s_VBZ -_: GFP_NNP (_( 18_CD -_: 20_CD )_) ,_, α_NN 
        s_VBZ -_: GFP_NNP (_( 92_CD -_: 94_CD )_) ,_, α_NN 
        s_VBZ -_: GFP_NNP (_( N_NNP )_) ,_, or_CC α_NN 
        s_VBZ -_: GFP_NNP (_( C_NNP )_) were_VBD higher_JJR than_IN in_IN cells_NNS
        expressing_VBG vector_NN alone_RB (_( figure_NN 5_CD A_DT )_) ._. However_RB ,_, only_RB in_IN cells_NNS
        expressing_VBG α_NN 
        s_VBZ -_: GFP_NNP (_( 92_CD -_: 94_CD )_) were_VBD these_DT differences_NNS
        statistically_RB significant_JJ (_( p_NN <_NN 0_CD ._. 05_CD )_) ._. The_DT basal_NN and_CC
        stimulated_VBN activities_NNS of_IN α_NN 
        s_VBZ -_: GFP_NNP (_( 92_CD -_: 94_CD )_) were_VBD less_JJR than_IN those_DT of_IN α_NN 
        s_VBZ ,_, although_IN these_DT differences_NNS were_VBD not_RB
        statistically_RB significant_JJ (_( p_NN <_NN 0_CD ._. 05_CD )_) ._. The_DT remaining_VBG 10_CD
        of_IN the_DT 12_CD fusion_NN proteins_NNS exhibited_VBN no_DT detectable_JJ activity_NN ._.
        One_CD possible_JJ explanation_NN for_IN the_DT decreased_VBN activities_NNS of_IN
        the_DT α_NN 
        s_VBZ -_: GFP_NNP fusion_NN proteins_NNS relative_JJ to_TO α_NN 
        s_VBZ 
        EE_NNP would_MD be_VB a_DT decrease_NN in_IN protein_NN
        expression_NN level_NN ._. Cell_NNP fractionation_NN and_CC immunoblotting_VBG
        with_IN an_DT anti-_NN EE_NNP monoclonal_NN antibody_NN showed_VBD that_IN both_DT α_NN 
        s_VBZ -_: GFP_NNP (_( 92_CD -_: 94_CD )_) and_CC α_NN 
        s_VBZ -_: GFP_NNP (_( 18_CD -_: 20_CD )_) were_VBD expressed_VBN at_IN lower_JJR
        levels_NNS than_IN α_NN 
        s_VBZ 
        EE_NNP ,_, in_IN contrast_NN to_TO α_NN 
        s_VBZ -_: GFP_NNP (_( N_NNP )_) and_CC α_NN 
        s_VBZ -_: GFP_NNP (_( C_NNP )_) (_( figure_NN 5_CD B_NNP )_) ._.
        Interpreting_NNP these_DT results_NNS in_IN the_DT context_NN of_IN the_DT
        structure_NN of_IN α_NN 
        s_VBZ leads_VBZ to_TO a_DT surprising_JJ result_NN ._. A_DT
        rational_JJ approach_NN to_TO designing_VBG a_DT fluorescent_NN ,_, functional_JJ α_NN 
        s_VBZ -_: GFP_NNP fusion_NN protein_NN would_MD have_VB most_RBS
        likely_RB targeted_VBN the_DT exposed_VBN loops_NNS [_NN e_SYM ._. g_SYM ._. [_NN 8_CD ]_NN ]_NN ,_, yet_RB these_DT
        insertions_NNS were_VBD not_RB functional_JJ ._. The_DT most_RBS functional_JJ protein_NN
        was_VBD produced_VBN by_IN the_DT insertion_NN of_IN GFP_NNP into_IN an_DT α-helix_JJ that_IN
        one_PRP would_MD have_VB avoided_VBN (_( figure_NN 3_LS )_) ._.
        The_DT discovery_NN that_IN all_DT of_IN the_DT in-frame_JJ insertions_NNS in_IN α_NN 
        s_VBZ produced_VBN truncated_JJ fluorescent_NN fusion_NN
        proteins_NNS suggested_VBD that_IN we_PRP could_MD identify_VB in_IN frame_NN
        insertions_NNS by_IN transiently_RB expressing_VBG all_DT of_IN the_DT transposed_JJ
        clones_NNS and_CC visually_RB screening_NN them_PRP for_IN fluorescence_NN ._. This_DT
        alternative_JJ screening_NN strategy_NN could_MD be_VB particularly_RB useful_JJ
        for_IN large_JJ coding_VBG regions_NNS where_WRB a_DT PCR-based_NNP screen_NN might_MD
        fail_VB ._. To_TO reduce_VB the_DT number_NN of_IN transient_JJ transfections_NNS
        required_VBN ,_, a_DT second_JJ transposon_NN was_VBD created_VBN with_IN enhanced_VBN
        cyan_JJ fluorescent_NN protein_NN (_( ECFP_NNP )_) ._. Two_CD separate_JJ
        transpositions_NNS with_IN the_DT different_JJ colored_VBN transposons_NNS ,_,
        followed_VBN by_IN co-transfections_JJ in_IN the_DT visual_JJ screen_NN (_( one_CD
        potential_JJ green_JJ clone_NN and_CC one_CD potential_JJ cyan_JJ clone_NN per_IN
        well_RB )_) ,_, can_MD identify_VB twice_RB as_IN many_JJ in-frame_JJ insertions_NNS in_IN a_DT
        given_VBN number_NN of_IN transfections_NNS ._. This_DT approach_NN could_MD be_VB
        expanded_VBN to_TO encompass_VB many_JJ different_JJ fluorophores_NNS ._.
        In_IN the_DT experiments_NNS with_IN α_NN 
        s_VBZ ,_, several_JJ clones_NNS were_VBD recovered_VBN with_IN
        identical_JJ transposon_NN insertions_NNS ._. This_DT is_VBZ consistent_JJ with_IN
        previous_JJ reports_NNS of_IN 
        Tn_NNP 5_CD preferentially_RB inserting_VBG into_IN
        particular_JJ locations_NNS in_IN the_DT target_NN sequence_NN [_NN 17_CD 18_CD ]_NN ._.
        Since_IN these_DT "_'' hotspots_NNS "_'' could_MD become_VB a_DT limiting_VBG factor_NN in_IN
        the_DT number_NN of_IN unique_JJ insertions_NNS recovered_VBD within_IN a_DT target_NN
        sequence_NN ,_, the_DT second_JJ reading_NN frame_NN through_IN the_DT 
        Tn_NNP 5_CD MEs_NNP was_VBD used_VBN for_IN the_DT ECFP_NNP
        transposon_NN ._. This_DT doubles_VBZ the_DT number_NN of_IN potentially_RB useful_JJ
        insertion_NN sites_NNS within_IN a_DT given_VBN target_NN sequence_NN ._.
        The_DT glutamate_NN receptor_NN subunit_NN GluR_NNP 1_CD [_NN 19_CD ]_NN was_VBD used_VBN to_TO
        test_VB the_DT new_JJ transposons_NNS and_CC the_DT visual_JJ screening_NN process_NN ._.
        Independent_JJ transpositions_NNS of_IN the_DT GluR_NNP 1_CD plasmid_NN were_VBD
        performed_VBN with_IN the_DT EGFP_NNP and_CC ECFP_NNP transposons_NNS
        (_( <_NN TgPT-_NNP 0_CD >_NN and_CC <_NN TcPT-_NNP 1_CD >_NN ,_, respectively_RB )_) ._. In_IN 288_CD
        co-transfections_JJ ,_, there_EX were_VBD 20_CD wells_NNS with_IN EGFP_NNP
        fluorescence_NN ,_, 21_CD wells_NNS with_IN ECFP_NNP fluorescence_NN ,_, and_CC 2_CD wells_NNS
        with_IN both_DT EGFP_NNP and_CC ECFP_NNP fluorescence_NN ._. Sequencing_NNP revealed_VBD
        35_CD unique_JJ insertions_NNS (_( 17_CD <_NN TgPT-_NNP 0_CD >_NN and_CC 18_CD
        <_NN TcPT-_NNP 1_CD >_NN )_) and_CC 10_CD repetitive_JJ insertions_NNS (_( figure_NN 6_CD A_DT )_) ._.
        The_DT recovery_NN of_IN 45_CD fluorescent_NN clones_NNS from_IN 576_CD colonies_NNS
        (_( 7_CD ._. 8_CD %_NN )_) agrees_VBZ with_IN the_DT predicted_VBN frequency_NN of_IN
        transpositions_NNS resulting_VBG in_IN GluR_NNP 1_CD -_: EGFP_NNP /_NN ECFP_NNP fusions_NNS (_( 7_CD ._. 7_CD %_NN )_) ,_,
        which_WDT is_VBZ consistent_JJ with_IN the_DT interpretation_NN that_IN all_DT
        in-frame_JJ insertions_NNS produce_VBP a_DT fluorescent_NN protein_NN ._. Clones_NNP
        representing_VBG unique_JJ fluorescent_NN fusion_NN proteins_NNS were_VBD
        digested_VBN with_IN 
        Srf_NNP I_PRP to_TO remove_VB the_DT 
        Kan_NNP 
        r_LS selection_NN cassette_NN and_CC re-ligated_JJ
        to_TO generate_VB full-length_JJ GluR_NNP 1_CD -_: EGFP_NNP /_NN ECFP_NNP fusions_NNS ._. These_DT
        fusion_NN proteins_NNS were_VBD screened_VBD ,_, in_IN transiently_RB transfected_JJ
        HEK_NNP 293_CD cells_NNS ,_, for_IN glutamate-gated_JJ ion_NN channel_NN function_NN ._. Of_IN
        the_DT 29_CD unique_JJ tribrid_NN fusion_NN constructs_NNS tested_VBN ,_, all_DT produce_VBP
        detectable_JJ fluorescence_NN and_CC 6_CD were_VBD functional_JJ (_( figure_NN
        6_CD B_NNP )_) ._.
      
      
        Discussion_NNP
        Creating_NNP functional_JJ ,_, fluorescent_NN fusion_NN proteins_NNS
        involves_VBZ finding_VBG a_DT permissive_JJ site_NN for_IN the_DT insertion_NN of_IN
        GFP_NNP ,_, a_DT process_NN that_IN in_IN most_JJS cases_NNS still_RB involves_VBZ some_DT
        guesswork_NN ._. The_DT results_NNS of_IN both_DT the_DT α_NN 
        s_VBZ and_CC GluR_NNP 1_CD transpositions_NNS illustrate_VBP
        this_DT point_NN ._. Based_VBN on_IN previous_JJ studies_NNS with_IN the_DT G_NNP protein_NN
        subunit_NN α_NN 
        q_NN [_NN 8_CD ]_NN we_PRP anticipated_VBD that_IN an_DT insertion_NN
        within_IN an_DT exterior_NN flexible_JJ loop_NN region_NN of_IN α_NN 
        s_VBZ would_MD be_VB most_RBS likely_JJ to_TO produce_VB a_DT
        functional_JJ fusion_NN protein_NN ._. Surprisingly_RB ,_, the_DT α_NN 
        s_VBZ fusion_NN protein_NN that_WDT was_VBD the_DT most_RBS
        functional_JJ ,_, α_NN 
        s_VBZ -_: GFP_NNP (_( 92_CD -_: 94_CD )_) ,_, resulted_VBD from_IN an_DT
        insertion_NN into_IN an_DT α_NN helix_NN (_( figure_NN 3_LS )_) ,_, while_IN the_DT insertions_NNS
        in_IN exposed_VBN loops_NNS ,_, α_NN 
        s_VBZ -_: GFP_NNP (_( 67_CD -_: 69_CD )_) and_CC α_NN 
        s_VBZ -_: GFP_NNP (_( 188_CD -_: 190_CD )_) ,_, were_VBD not_RB functional_JJ ._.
        Similarly_RB ,_, in_IN the_DT case_NN of_IN GluR_NNP 1_CD ,_, one_CD of_IN the_DT insertions_NNS that_WDT
        produced_VBD a_DT functional_JJ channel_NN ,_, GluR_NNP 1_CD -_: GFP_NNP (_( 526_CD -_: 528_CD )_) ,_, was_VBD
        within_IN the_DT hydrophobic_JJ region_NN thought_VBD to_TO be_VB the_DT first_JJ
        transmembrane_NN domain_NN (_( see_VB Additional_JJ File_NNP :_: Figure_NN 7_CD )_) ._.
        Additionally_RB ,_, within_IN a_DT given_VBN region_NN of_IN GluR_NNP 1_CD ,_, one_CD insertion_NN
        will_MD produce_VB a_DT functional_JJ channel_NN while_IN another_DT nearby_JJ
        insertion_NN does_VBZ not_RB (_( e_SYM ._. g_SYM ._. the_DT intracellular_NN carboxy-terminus_JJ
        region_NN or_CC the_DT amino_JJ terminus_JJ between_IN amino_JJ acids_NNS 210_CD and_CC
        330_CD )_) ._. The_DT reasons_NNS for_IN these_DT discrepancies_NNS are_VBP not_RB
        obvious_JJ ._.
        The_DT discovery_NN that_IN GFP_NNP will_MD still_RB fold_VB and_CC form_VB a_DT
        fluorophore_NN when_WRB placed_VBN virtually_RB anywhere_RB in_IN another_DT
        coding_VBG region_NN suggests_VBZ that_IN the_DT limiting_VBG step_NN in_IN the_DT
        process_NN is_VBZ whether_IN the_DT target_NN protein_NN it_PRP is_VBZ inserted_VBN into_IN
        folds_NNS and_CC functions_NNS correctly_RB ._. Indeed_RB ,_, GFP_NNP fusion_NN
        constructs_NNS have_VBP been_VBN used_VBN to_TO assay_NN ,_, and_CC improve_VB upon_RB ,_, the_DT
        folding_NN of_IN a_DT variety_NN of_IN proteins_NNS in_IN a_DT bacterial_JJ expression_NN
        system_NN [_NN 20_CD ]_NN ._. The_DT relatively_RB random_JJ nature_NN of_IN the_DT
        transposition_NN events_NNS we_PRP recovered_VBD in_IN this_DT study_NN suggests_VBZ
        that_IN it_PRP might_MD be_VB possible_JJ to_TO insert_VB GFP_NNP at_IN nearly_RB every_DT
        position_NN in_IN a_DT given_VBN protein_NN ,_, but_CC there_EX are_VBP two_CD potential_JJ
        limits_NNS ._. First_LS ,_, the_DT laws_NNS of_IN probability_NN predict_VBP that_IN there_EX
        will_MD be_VB rapidly_RB diminishing_VBG returns_NNS in_IN the_DT search_NN for_IN
        unique_JJ 
        Tn_NNP 5_CD insertions_NNS as_IN one_CD recovers_VBZ each_DT
        additional_JJ clone_NN ._. Second_JJ ,_, the_DT behavior_NN of_IN the_DT 
        Tn_NNP 5_CD transposon_NN is_VBZ not_RB entirely_RB
        random_JJ ._. Goryshin_NNP and_CC colleagues_NNS [_NN 18_CD ]_NN have_VBP shown_VBN that_IN
        there_EX is_VBZ a_DT weak_JJ consensus_NN site_NN for_IN 
        Tn_NNP 5_CD insertion_NN which_WDT is_VBZ consistent_JJ
        with_IN our_PRP$ results_NNS ._. It_PRP appears_VBZ that_IN the_DT resolution_NN limit_NN will_MD
        be_VB an_DT insertion_NN each_DT three_CD amino_JJ acids_NNS on_IN average_JJ in_IN a_DT
        target_NN protein_NN ._.
        Inserting_NNP a_DT reporter_NN domain_NN such_JJ as_IN GFP_NNP into_IN another_DT
        protein_NN always_RB has_VBZ the_DT potential_NN of_IN perturbing_VBG the_DT target_NN
        and_CC destroying_VBG it_PRP 's_VBZ ability_NN to_TO function_VB ._. In_IN this_DT study_NN 16_CD %_NN
        of_IN the_DT tribrid_NN fusion_NN proteins_NNS were_VBD still_RB functional_JJ ._. One_CD
        explanation_NN for_IN why_WRB GFP_NNP can_MD be_VB used_VBN for_IN internal_JJ insertion_NN
        is_VBZ that_IN the_DT N-_NNP and_CC C-_NNP termini_NN of_IN GFP_NNP exit_NN the_DT structure_NN
        quite_RB close_RB to_TO one_CD another_DT and_CC are_VBP unlikely_JJ to_TO displace_VB the_DT
        surrounding_VBG domains_NNS of_IN the_DT target_NN protein_NN a_DT great_JJ deal_NN ._.
        This_DT is_VBZ analogous_JJ to_TO the_DT use_NN of_IN the_DT bovine_JJ pancreatic_JJ
        trypsin_NN inhibitor_NN for_IN internal_JJ insertions_NNS [_NN 21_CD ]_NN ._. The_DT
        transposons_NNS described_VBD here_RB could_MD potentially_RB be_VB improved_VBN
        upon_IN by_IN optimizing_VBG the_DT length_NN and_CC flexibility_NN of_IN the_DT
        linkers_NNS between_IN the_DT target_NN and_CC the_DT GFP_NNP ._. Another_DT potential_JJ
        improvement_NN to_TO the_DT process_NN would_MD be_VB to_TO use_VB bacterial_JJ
        expression_NN to_TO screen_VB for_IN transposon_NN insertions_NNS that_WDT produce_VBP
        a_DT fluorescent_NN protein_NN ._. This_DT could_MD ,_, however_RB ,_, be_VB problematic_JJ
        with_IN proteins_NNS from_IN the_DT mammalian_JJ nervous_JJ sytem_NN ,_, such_JJ as_IN ion_NN
        channels_NNS ,_, that_WDT are_VBP difficult_JJ to_TO express_VB in_IN bacteria_NNS ._.
        The_DT approach_NN described_VBD here_RB should_MD speed_VB the_DT discovery_NN
        of_IN genetically_RB encodable_JJ fluorescent_NN sensors_NNS ._. The_DT
        pioneering_JJ work_NN of_IN Siegel_NNP and_CC Isacoff_NNP showed_VBD that_IN GFP_NNP
        placed_VBD within_IN a_DT portion_NN of_IN the_DT Shaker_NNP K_NNP +_NN channel_NN C-_NNP terminus_JJ
        produced_VBD a_DT fluorophore_NN that_WDT responded_VBD to_TO changes_NNS in_IN
        membrane_NN voltage_NN [_NN 5_CD ]_NN ,_, but_CC they_PRP built_VBD a_DT number_NN of_IN
        different_JJ constructs_NNS before_IN finding_VBG one_CD that_DT worked_VBD ._.
        Similarly_RB ,_, Ataka_NNP and_CC Pieribone_NNP created_VBD an_DT EGFP-Na_NNP +_NN channel_NN
        fusion_NN protein_NN that_IN changes_NNS fluorescence_NN in_IN response_NN to_TO
        membrane_NN depolarizations_NNS on_IN a_DT time-scale_JJ that_WDT would_MD be_VB
        sufficent_NN to_TO image_NN action_NN potentials_NNS ._. This_DT discovery_NN ,_,
        however_RB ,_, was_VBD the_DT result_NN of_IN designing_VBG ,_, building_NN ,_, and_CC testing_NN
        eight_CD different_JJ tribrid_NN fusion_NN proteins_NNS [_NN 22_CD ]_NN ._. Little_NNP is_VBZ
        known_VBN about_IN the_DT mechanism_NN whereby_WRB changes_NNS in_IN channel_NN
        conformation_NN are_VBP converted_VBN to_TO changes_NNS in_IN the_DT fluorophore_NN ,_,
        so_IN it_PRP remains_VBZ to_TO be_VB determined_VBN whether_IN GFP_NNP can_MD signal_VB
        conformational_NN changes_NNS in_IN other_JJ kinds_NNS of_IN proteins_NNS ._.
        Nevertheless_RB ,_, the_DT use_NN of_IN the_DT transposons_NNS described_VBD here_RB
        should_MD shift_VB the_DT work_NN from_IN building_VBG the_DT constructs_NNS to_TO
        devising_VBG high_JJ throughput_NN assays_NNS for_IN function_NN ._.
        Finally_RB ,_, random_JJ GFP_NNP tagging_VBG will_MD facilitate_VB the_DT creation_NN
        of_IN potential_JJ fluorescence_NN resonance_NN energy_NN transfer_NN (_( FRET_NNP )_)
        reagents_NNS to_TO study_VB protein_NN interactions_NNS in_IN living_VBG systems_NNS ._.
        To_TO date_NN ,_, a_DT few_JJ studies_NNS have_VBP demonstrated_VBN the_DT potential_JJ
        power_NN of_IN GFP-FRET_NNP by_IN labeling_VBG different_JJ proteins_NNS [_NN 6_CD 23_CD 24_CD
        25_CD 26_CD ]_NN or_CC by_IN fusing_NN two_CD different_JJ fluorophores_NNS to_TO the_DT same_JJ
        protein_NN [_NN 27_CD 28_CD 29_CD 30_CD 31_CD 32_CD ]_NN ._. Creating_NNP efficent_NN donor_NN and_CC
        acceptor_NN fusion_NN proteins_NNS is_VBZ difficult_JJ ,_, however_RB ,_, because_IN
        FRET_NNP only_RB occurs_VBZ when_WRB the_DT two_CD fluorophores_NNS are_VBP attached_VBN to_TO
        surfaces_VBZ that_WDT are_VBP very_RB close_RB to_TO one_CD another_DT ._. The_DT approach_NN
        described_VBD here_RB makes_VBZ it_PRP possible_JJ to_TO rapidly_RB generate_VB
        libraries_NNS of_IN potential_JJ donor_NN and_CC acceptor_NN tribrid_NN fusion_NN
        proteins_NNS that_WDT can_MD be_VB screened_VBD ,_, in_IN pairwise_NN combinations_NNS ,_,
        for_IN function_NN and_CC FRET_NNP signals_NNS ._.
        Additional_JJ File_NNP
        Figure_NN 7_CD
        Click_NNP here_RB for_IN file_NN
      
      
        Conclusions_NNP
        The_DT transposons_NNS described_VBD here_RB make_VB it_PRP possible_JJ to_TO
        rapidly_RB generate_VB large_JJ numbers_NNS of_IN different_JJ GFP_NNP fusion_NN
        proteins_NNS ._. The_DT results_NNS show_VBP that_IN GFP_NNP can_MD be_VB inserted_VBN into_IN a_DT
        wide_JJ variety_NN of_IN other_JJ protein_NN domains_NNS and_CC it_PRP will_MD continue_VB
        to_TO fold_VB and_CC form_VB a_DT fluorophore_NN ._. The_DT rapid_JJ and_CC random_JJ nature_NN
        of_IN the_DT transposition_NN process_NN makes_VBZ it_PRP possible_JJ to_TO generate_VB
        and_CC screen_VB many_JJ different_JJ fusion_NN constructs_NNS to_TO identify_VB
        those_DT that_WDT continue_VBP to_TO function_VB ._. In_IN the_DT case_NN of_IN the_DT two_CD
        proteins_NNS tested_VBN here_RB ,_, roughly_RB 1_CD in_IN 6_CD of_IN the_DT fusion_NN proteins_NNS
        retained_VBD their_PRP$ signaling_VBG function_NN ,_, and_CC the_DT random_JJ nature_NN of_IN
        the_DT transposition_NN process_NN revealed_VBD permissive_JJ sites_NNS for_IN
        insertion_NN that_WDT would_MD not_RB have_VB been_VBN predicted_VBN on_IN the_DT basis_NN
        of_IN structural_JJ or_CC functional_JJ models_NNS of_IN how_WRB that_DT protein_NN
        works_NNS ._. This_DT simple_JJ tool_NN should_MD speed_VB the_DT search_NN for_IN a_DT wide_JJ
        variety_NN of_IN new_JJ biological_JJ probes_NNS for_IN the_DT study_NN of_IN nervous_JJ
        system_NN ._.
      
      
        Materials_NNS and_CC Methods_NNP
        PCR_NNP and_CC standard_NN subcloning_VBG procedures_NNS were_VBD use_NN to_TO
        create_VB the_DT initial_JJ transposon_NN ,_, <_NN EGFP-V_NNP >_NN (_( full_JJ
        sequence_NN at_IN :_: http_NN :_: /_NN /_NN momotion_NN ._. med_JJ ._. yale_NN ._. edu_NN )_) ._. The_DT 
        Tn_NNP 5_CD MEs_NNP were_VBD added_VBN to_TO the_DT 5_CD '_POS and_CC 3_CD '_POS
        ends_NNS of_IN an_DT EGFP_NNP coding_VBG sequence_NN ,_, with_IN a_DT 
        Srf_NNP I_PRP restriction_NN site_NN at_IN its_PRP$ 3_CD '_POS end_NN ,_,
        such_JJ that_IN one_CD continuous_JJ reading_NN frame_NN extended_VBN through_IN
        both_DT MEs_NNP and_CC EGFP_NNP (_( figure_NN 2_LS )_) ._. To_TO add_VB antibiotic_JJ selection_NN ,_,
        the_DT 
        Kan_NNP 
        r_LS gene_NN from_IN pUniV_NN 5_CD -_: His-_NNP TOPO_NNP ™_NN
        (_( Invitrogen_NNP ,_, Carlsbad_NNP ,_, CA_NNP )_) was_VBD flanked_JJ with_IN 
        Srf_NNP I_PRP sites_NNS and_CC inserted_VBN into_IN the_DT
        transposon_NN ._. The_DT improved_VBN transposons_NNS ,_, <_NN TgPT-_NNP 0_CD >_NN and_CC
        <_NN TcPT-_NNP 1_CD >_NN ,_, were_VBD created_VBN in_IN the_DT same_JJ way_NN as_IN
        <_NN EGFP-V_NNP >_NN ,_, but_CC 
        Asc_NNP I_PRP sites_NNS were_VBD added_VBN to_TO facilitate_VB
        changing_VBG the_DT fluorescent_NN protein_NN at_IN a_DT later_JJ date_NN
        (_( supplemental_JJ material_NN )_) ._. In_IN addition_NN ,_, the_DT two_CD different_JJ
        reading_NN frames_NNS present_JJ in_IN the_DT MEs_NNP were_VBD used_VBN to_TO create_VB the_DT
        two_CD different_JJ transposons_NNS ,_, and_CC ECFP_NNP was_VBD used_VBN in_IN place_NN of_IN
        EGFP_NNP in_IN <_NN TcPT-_NNP 1_CD >_NN ._. A_DT primer_NN complementary_JJ to_TO the_DT 19_CD bp_NN 
        Tn_NNP 5_CD ME_NNP (_( 5_CD '_POS -_: CTGTCTCTTATACACATCT-_NNP 3_CD '_POS )_)
        was_VBD used_VBN to_TO amplify_VB the_DT transposons_NNS (_( 1_CD cycle_NN at_IN 95_CD °_NN C_NNP for_IN
        3_CD :_: 30_CD min_NN ._. ,_, 24_CD cycles_NNS of_IN 95_CD °_NN C_NNP for_IN 30_CD sec_NN 47_CD °_NN C_NNP for_IN 30_CD sec_NN
        72_CD °_NN C_NNP for_IN 1_CD min_NN ._. ,_, 1_CD cycle_NN at_IN 72_CD °_NN C_NNP for_IN 5_CD min_NN ._. )_) with_IN 
        Pfu_NNP polymerase_NN (_( Stratagene_NNP ,_, La_NNP Jolla_NNP ,_,
        CA_NNP )_) ._. The_DT PCR_NNP product_NN was_VBD purified_JJ and_CC concentrated_VBN with_IN the_DT
        Geneclean_NNP II_NNP kit_NN (_( Bio_NNP 101_CD Inc_NNP ._. ,_, Vista_NNP ,_, CA_NNP )_) and_CC eluted_JJ in_IN 1_CD X_NNP
        TE_NNP buffer_NN ._. 0_CD ._. 2_CD fmoles_NNS of_IN transposon_NN were_VBD incubated_JJ with_IN 5_CD ._. 0_CD
        μL_NN of_IN EZ_NNP :_: :_: TN_NNP ™_NN transposase_NN (_( Epicentre_NNP Technologies_NNPS )_) in_IN 25_CD %_NN
        glycerol_NN at_IN 25_CD °_NN C_NNP for_IN 30_CD min_NN ._.
        Molar_NNP equivalents_NNS of_IN transposon_NN and_CC target_NN plasmid_NN (_( 0_CD ._. 4_LS
        fmoles_NNS ea_NN ._. )_) were_VBD incubated_JJ in_IN reaction_NN buffer_NN (_( 50_CD mM_NN
        Tris-acetate_NNP (_( pH_NN 7_CD ._. 5_LS )_) ,_, 150_CD mM_NN potassium_NN acetate_NN ,_, 10_CD mM_NN
        magnesium_NN acetate_NN and_CC 4_CD mM_NN spermidine_NN )_) at_IN 37_CD °_NN C_NNP for_IN 2_CD hr_NN in_IN
        a_DT 10_CD μL_NN reaction_NN ._. Transposition_NNP was_VBD stopped_VBN by_IN adding_VBG 1_CD μL_NN
        of_IN 1_CD %_NN SDS_NNP and_CC incubating_VBG at_IN 70_CD °_NN C_NNP for_IN 10_CD min_NN ._. Top_JJ 10_CD F_NN '_'' 
        E_NNP ._. coli_NNS (_( Stratagene_NNP )_) were_VBD transformed_VBN
        with_IN 1_CD μL_NN of_IN the_DT transposition_NN reaction_NN and_CC plated_JJ on_IN LB_NNP
        agar_NN with_IN either_DT ampicillin_NN (_( 100_CD μg_NN /_NN mL_NN )_) and_CC kanamycin_NN (_( 50_CD
        μg_NN /_NN mL_NN )_) to_TO recover_VB transposed_JJ clones_NNS ,_, or_CC ampicillin_NN (_( 100_CD
        μg_NN /_NN mL_NN )_) alone_RB to_TO establish_VB the_DT transposition_NN efficiency_NN ._.
        The_DT cDNA_NN encoding_VBG the_DT rat_NN α_NN 
        s_VBZ [_NN 33_CD ]_NN ,_, modified_VBN to_TO carry_VB the_DT EE_NNP
        epitope_NN [_NN 34_CD ]_NN ,_, was_VBD in_IN pcDNA_NN 1_CD /_NN Amp_NNP (_( Invitrogen_NNP )_) ._. GFP_NNP was_VBD
        added_VBN to_TO the_DT N-_NNP or_CC C-_NNP terminus_JJ of_IN α_NN 
        s_VBZ to_TO create_VB end-labeled_JJ constructs_NNS for_IN
        comparison_NN with_IN the_DT transposed_JJ GFP_NNP tribrid_NN fusion_NN proteins_NNS ._.
        The_DT amino-labeled_JJ clone_NN ,_, GFP-_NNP [_NN GGGPSGGGGS_NNP ]_NN -_: α_NN 
        s_VBZ EE_NNP ,_, and_CC carboxy-labeled_JJ clone_NN ,_, α_NN 
        s_VBZ EE-_NNP [_NN SGGGGSGQH_NNP ]_NN -_: GFP_NNP ,_, were_VBD generated_VBN via_IN
        overlap_VB extension_NN [_NN 35_CD ]_NN ._. Linker_NNP sequences_NNS are_VBP in_IN
        brackets_NNS ._. The_DT flip_JJ variant_NN of_IN rat_NN GluR_NNP 1_CD was_VBD in_IN the_DT CMV_NNP
        expression_NN plasmid_NN pRK_NN 5_CD (_( a_DT generous_JJ gift_NN from_IN Derek_NNP Bowie_NNP ,_,
        Emory_NNP University_NNP ,_, Atlanta_NNP ,_, GA_NNP )_) ._.
        PCR_NNP screening_NN for_IN <_NN EGFP-V_NNP >_NN insertions_NNS within_IN the_DT α_NN
        
        s_VBZ 
        EE_NNP coding_VBG region_NN was_VBD performed_VBN using_VBG
        a_DT protocol_NN described_VBN by_IN Cease_NNP et_CC al_NN ._. [_NN 36_CD ]_NN using_VBG an_DT upper_JJ
        primer_NN complimentary_JJ to_TO the_DT 5_CD '_POS UTR_NNP
        (_( 5_CD '_POS -_: GCTCCCGCGGCTCCTGCTCTGCTC-_NNP 3_CD '_POS )_) ,_, and_CC a_DT lower_JJR primer_NN
        complimentary_JJ to_TO EGFP_NNP (_( 5_CD '_POS -_: GCCGTCGCCGATGGGGGTGTTCTG-_NNP 3_CD '_'' ._. The_DT
        clones_NNS that_WDT produced_VBD clear_JJ PCR_NNP products_NNS within_IN the_DT expected_VBN
        size_NN range_NN were_VBD then_RB miniprepped_JJ (_( QIAgen_NNP ,_, Germantown_NNP ,_,
        MD_NNP )_) ._.
        Insertion_NNP sites_NNS were_VBD identified_VBN for_IN all_DT PCR-positive_NNP
        <_NN EGFP-V_NNP >_NN transposed_JJ clones_NNS and_CC all_DT fluorescent_NN
        <_NN TgPT-_NNP 0_CD >_NN /_NN <_NN TcPT-_NNP 1_CD >_NN transposed_JJ clones_NNS by_IN
        sequencing_VBG out_IN of_IN the_DT transposon_NN with_IN a_DT primer_NN
        complimentary_JJ to_TO the_DT EGFP_NNP /_NN ECFP_NNP coding_VBG region_NN
        (_( 5_CD '_POS -_: tggccgtttacgtcgccgtcca-_NN 3_CD '_POS )_) ._. 
        Srf_NNP I_PRP restriction_NN digestion_NN was_VBD then_RB
        used_VBN to_TO remove_VB the_DT 
        Kan_NNP 
        r_LS cassette_NN from_IN the_DT clones_NNS carrying_VBG
        in-frame_JJ insertions_NNS ,_, thereby_RB creating_VBG a_DT sequence_NN encoding_VBG a_DT
        full-length_JJ fusion_NN protein_NN ._. After_IN digestion_NN and_CC
        re-ligation_JJ ,_, Top_JJ 10_CD F_NN '_'' 
        E_NNP ._. coli_NNS were_VBD transformed_VBN with_IN 1_CD μL_NN of_IN
        the_DT ligation_NN reaction_NN and_CC plated_JJ on_IN LB_NNP agar_NN containing_VBG
        ampicillin_NN ._. The_DT colonies_NNS were_VBD re-plated_JJ the_DT following_VBG day_NN
        on_IN ampicillin_NN and_CC kanamycin_NN to_TO verify_VB loss_NN of_IN the_DT 
        Kan_NNP 
        r_LS ._.
        The_DT fusion_NN proteins_NNS were_VBD transiently_RB expressed_VBN in_IN HEK_NNP
        293_CD cells_NNS [_NN 37_CD ]_NN ._. Transfections_NNP were_VBD done_VBN using_VBG
        Lipofectamine_NNP 2000_CD (_( Gibco_NNP BRL_NNP )_) ._. Images_NNP were_VBD collected_VBN from_IN
        live_VB cells_NNS 20_CD -_: 48_CD hr_NN later_RB on_IN an_DT inverted_JJ Zeiss_NNP microscope_NN
        fitted_JJ with_IN computer_NN controlled_VBN (_( IPLabs_NNP ,_, Scanalytics_NNP )_)
        filter_NN wheels_NNS (_( Ludl_NNP Electronics_NNP )_) on_IN the_DT excitation_NN and_CC
        emission_NN paths_NNS ._. EGFP_NNP was_VBD imaged_JJ with_IN an_DT FITC_NNP filter_NN set_VBD ,_,
        while_IN ECFP_NNP was_VBD distinguished_VBN from_IN EGFP_NNP in_IN co-expression_JJ
        experiments_NNS by_IN changing_VBG both_DT the_DT excitation_NN and_CC emission_NN
        filter_NN sets_NNS (_( Exciters_NNP :_: 440_CD AF_NNP 21_CD &_CC 500_CD AF_NNP 25_CD ,_, Dichroic_NNP cat_NN #_#
        XF_NNP 2063_CD ,_, Emitters_NNP 480_CD AF_NNP &_CC 545_CD AF_NNP 35_CD ;_: Omega_NNP ,_, Brattleboro_NNP ,_,
        VT_NNP )_) ._.
        α_NN 
        s_VBZ -_: GFP_NNP fusion_NN proteins_NNS were_VBD assayed_JJ for_IN
        the_DT ability_NN to_TO stimulate_VB adenylyl_NN cyclase_NN in_IN response_NN to_TO
        luteinizing_VBG hormone_NN (_( LH_NNP )_) receptor_NN stimulation_NN [_NN 38_CD ]_NN ._. 10_CD
        6_CD HEK_NNP 293_CD cells_NNS /_NN 60_CD mm-dish_JJ were_VBD co-transfected_JJ with_IN 2_CD μg_NN of_IN
        plasmid_NN DNA_NNP encoding_VBG the_DT α_NN 
        s_VBZ -_: GFP_NNP fusion_NN protein_NN ,_, and_CC 0_CD ._. 2_CD μg_NN of_IN
        plasmid_NN DNA_NNP encoding_VBG the_DT rat_NN LH_NNP receptor_NN in_IN pCIS_NN [_NN 39_CD ]_NN ,_,
        using_VBG 10_CD μL_NN of_IN Lipofectamine_NNP 2000_CD ._. [_NN 3_CD H_NNP ]_NN -_: adenine-labeled_JJ
        cells_NNS were_VBD assayed_JJ for_IN cAMP_NN accumulation_NN after_IN incubation_NN
        at_IN 37_CD °_NN C_NNP for_IN 40_CD min_NN ._. in_IN the_DT presence_NN of_IN 1_CD mM_NN
        3_CD -_: isobutyl-_NN 1_CD -_: methylxanthine_NN (_( IBMX_NNP )_) a_DT phosphodiesterase_NN
        inhibitor_NN ,_, and_CC in_IN the_DT presence_NN or_CC absence_NN of_IN 7_CD ._. 5_CD ng_NN /_NN mL_NN
        human_JJ chorionic_JJ gonadotropin_NN (_( hCG_NN )_) ,_, as_IN described_VBN
        previously_RB ._. Conversion_NNP of_IN ATP_NNP to_TO cAMP_NN was_VBD expressed_VBN as_IN :_:
        10_CD 3_CD ×_NN [_NN 3_CD H_NNP ]_NN cAMP_NN /_NN (_( [_NN 3_CD H_NNP ]_NN ATP_NNP +_NN [_NN 3_CD H_NNP ]_NN cAMP_NN )_) ._.
        12_CD ×_NN 10_CD 6_CD HEK_NNP 293_CD cells_NNS were_VBD transfected_JJ ,_, using_VBG
        DEAE-dextran_NNP [_NN 40_CD ]_NN ,_, with_IN 25_CD μg_NN of_IN plasmid_NN DNA_NNP ._.
        Forty-eight_NNP hours_NNS after_IN transfection_NN ,_, cells_NNS were_VBD lysed_JJ and_CC
        membrane_NN and_CC supernatant_NN fractions_NNS harvested_VBN as_IN described_VBN
        previously_RB [_NN 8_CD ]_NN ._. 10_CD μg_NN of_IN membrane_NN proteins_NNS and_CC
        normalized_JJ volumes_NNS of_IN the_DT supernatants_NNS were_VBD resolved_VBN by_IN
        SDS-polyacrylamide_NNP electrophoresis_NNS (_( 10_CD %_NN )_) ,_, transferred_VBN to_TO
        nitrocellulose_NN ,_, and_CC probed_JJ with_IN a_DT monoclonal_NN antibody_NN to_TO
        the_DT EE_NNP epitope_NN [_NN 34_CD ]_NN ._. The_DT antigen-antibody_JJ complexes_NNS were_VBD
        visualized_JJ with_IN ECL_NNP chemiluminescence_NN (_( Amersham_NNP
        Biosciences_NNP ,_, Piscataway_NNP ,_, NJ_NNP )_) ._.
        Whole-cell_NNP patch_NN clamp_NN recording_NN was_VBD used_VBN to_TO test_VB the_DT
        GluR_NNP 1_CD fusion_NN proteins_NNS for_IN function_NN in_IN transiently_RB
        transfected_JJ HEK_NNP 293_CD cells_NNS as_RB previously_RB described_VBD [_NN 41_CD ]_NN ._.
        The_DT external_JJ solution_NN was_VBD (_( in_IN mM_NN )_) :_: 150_CD NaCl_NNP ,_, 3_CD KCl_NNP ,_, 2_CD CaCl_NNP 
        2_CD ,_, 1_CD MgCl_NNP 
        2_CD ,_, 5_CD glucose_NN ,_, 0_CD ._. 002_CD glycine_NN and_CC 10_CD
        HEPES_NNP (_( pH_NN 7_CD ._. 4_LS )_) ._. Patch_NNP pipettes_NNS were_VBD filled_VBN with_IN a_DT solution_NN
        containing_VBG (_( in_IN mM_NN )_) :_: 120_CD CsF_NNP ,_, 33_CD KOH_NNP ,_, 2_CD MgCl_NNP 
        2_CD ,_, 1_CD CaCl_NNP 
        2_CD ,_, 0_CD ._. 1_CD spermine_NN ,_, 10_CD HEPES_NNP ,_, and_CC 11_CD EGTA_NNP
        (_( pH_NN 7_CD ._. 4_LS )_) ._. Cyclothiazide_NNP was_VBD prepared_VBN as_IN a_DT 20_CD mM_NN stock_NN
        solution_NN in_IN DMSO_NNP and_CC diluted_VBN to_TO 100_CD μM_NN in_IN external_JJ
        solution_NN ._. All_DT chemicals_NNS were_VBD purchased_VBN from_IN Sigma_NNP ._. Drugs_NNS
        were_VBD applied_VBN with_IN a_DT rapid_JJ superfusion_NN system_NN made_VBN from_IN a_DT
        pulled_VBN theta_NN capillary_JJ ._. The_DT open_JJ tip_NN responses_NNS obtained_VBN
        with_IN this_DT system_NN had_VBD 10_CD -_: 90_CD %_NN rise-times_JJ of_IN 150_CD μs_NNS to_TO 300_CD
        μs_NNS ._.
      
      
        Authors_NNP '_'' contributions_NNS
        Author_NN 1_CD D_NNP ._. L_NNP ._. Sheridan_NNP carried_VBD out_RP the_DT design_NN and_CC
        construction_NN of_IN the_DT transposons_NNS ,_, conducted_VBD the_DT biochemical_JJ
        assays_NNS for_IN G-_NNP protein_NN signaling_VBG ,_, imaged_JJ the_DT living_VBG cells_NNS ,_,
        and_CC drafted_VBD the_DT manuscript_NN ._. Author_NN 2_CD C_NNP ._. H_NNP ._. Berlot_NNP provided_VBD
        critical_JJ reagents_NNS and_CC advice_NN for_IN all_DT portions_NNS of_IN the_DT
        G-_NNP protein_NN work_NN ._. Author_NN 3_CD A_DT ._. Robert_NNP screened_VBD the_DT Glutamate_NNP
        receptor_NN subunits_NNS for_IN function_NN ._. Authors_NNP 4_CD F_NN ._. M_NNP ._. Inglis_NNP and_CC
        5_CD K_NN ._. B_NNP ._. Jakobsdottir_NNP provided_VBD help_VB in_IN the_DT minipreparation_NN
        of_IN plasmid_NN DNA_NNP for_IN each_DT of_IN the_DT constructs_NNS ._. Authors_NNP 6_CD J_NNP ._. R_NN ._.
        Howe_NNP and_CC 7_CD T_NN ._. E_NNP ._. Hughes_NNP participated_VBD in_IN the_DT study_NN design_NN ,_,
        coordination_NN ,_, and_CC analysis_NN ._.
        All_DT authors_NNS read_VBP and_CC approved_VBD the_DT final_JJ manuscript_NN ._.
      
    
  
